0001209191-24-003091.txt : 20240212 0001209191-24-003091.hdr.sgml : 20240212 20240212161915 ACCESSION NUMBER: 0001209191-24-003091 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20240212 DATE AS OF CHANGE: 20240212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hait William CENTRAL INDEX KEY: 0001904791 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 24620208 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLAZA CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 3/A 1 doc3a.xml FORM 3/A SUBMISSION X0206 3/A 2022-01-03 2022-01-13 0 0000200406 JOHNSON & JOHNSON JNJ 0001904791 Hait William ONE JOHNSON & JOHNSON PLAZA NEW BRUNSWICK NJ 08933 0 1 0 0 See Remarks Common Stock 15996 D This Form 3/A is being filed to correct the number of shares of common stock reported in Table I of the original Form 3 filed on January 13, 2022, as amended by the Form 3/A filed on February 18, 2022 ("Amended Form 3"), which Amended Form 3 inadvertently reported 71,609 shares beneficially owned by the reporting person instead of the 15,996 shares reported herein. This Form 3/A is deemed to update the number of securities reported as beneficially owned in any Forms 4 subsequently filed by the reporting person through the date hereof. Title: EVP, Chief External Innovation and Medical Officer /s/ Raavi Deol, as attorney-in-fact for William Hait 2024-02-12